ID29629A - Tablet yang lapas-segera - Google Patents

Tablet yang lapas-segera

Info

Publication number
ID29629A
ID29629A IDW20010429A ID20010429A ID29629A ID 29629 A ID29629 A ID 29629A ID W20010429 A IDW20010429 A ID W20010429A ID 20010429 A ID20010429 A ID 20010429A ID 29629 A ID29629 A ID 29629A
Authority
ID
Indonesia
Prior art keywords
immediate
tape
Prior art date
Application number
IDW20010429A
Other languages
English (en)
Indonesian (id)
Inventor
Sigbrit Forsman
Christer Karlsson
Magnus Karlsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID29629A publication Critical patent/ID29629A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010429A 1998-09-03 1999-08-27 Tablet yang lapas-segera ID29629A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802973A SE9802973D0 (sv) 1998-09-03 1998-09-03 Immediate release tablet

Publications (1)

Publication Number Publication Date
ID29629A true ID29629A (id) 2001-09-06

Family

ID=20412467

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010429A ID29629A (id) 1998-09-03 1999-08-27 Tablet yang lapas-segera

Country Status (32)

Country Link
US (3) US6521253B1 (fr)
EP (2) EP1109537B1 (fr)
JP (2) JP4026678B2 (fr)
KR (2) KR20060097071A (fr)
CN (3) CN1544088A (fr)
AR (1) AR029313A1 (fr)
AT (1) ATE286385T1 (fr)
AU (1) AU746129B2 (fr)
BR (1) BR9913400A (fr)
CA (1) CA2341397C (fr)
CZ (1) CZ300830B6 (fr)
DE (1) DE69923074T2 (fr)
EE (1) EE200100134A (fr)
ES (1) ES2234296T3 (fr)
HU (1) HU227278B1 (fr)
ID (1) ID29629A (fr)
IL (2) IL141439A0 (fr)
IS (1) IS5869A (fr)
MY (1) MY124359A (fr)
NO (1) NO20011085L (fr)
NZ (2) NZ539749A (fr)
PL (1) PL195603B1 (fr)
PT (1) PT1109537E (fr)
RU (2) RU2252751C2 (fr)
SA (1) SA99200683B1 (fr)
SE (1) SE9802973D0 (fr)
SK (1) SK285507B6 (fr)
TR (2) TR200502188T2 (fr)
TW (1) TW561056B (fr)
UA (1) UA75567C2 (fr)
WO (1) WO2000013671A1 (fr)
ZA (1) ZA200101762B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
HUP0301390A3 (en) * 2000-06-22 2005-04-28 Novartis Ag Oral pharmaceutical composition containing valsartan
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CN1642546A (zh) * 2002-03-28 2005-07-20 帝人株式会社 含有单一晶型的固体制剂
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
CA2552114A1 (fr) * 2003-12-31 2005-07-21 Actavis Group Hf Formulations solides d'administration de galantamine
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
JP5344289B2 (ja) * 2006-06-29 2013-11-20 株式会社ツムラ 漢方エキス含有錠剤組成物
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5583659B2 (ja) * 2009-03-13 2014-09-03 富山化学工業株式会社 ６−フルオロ−３−ヒドロキシ−２−ピラジンカルボキサミド含有錠剤および造粒末
CA3146333A1 (fr) 2009-03-18 2010-09-23 Resverlogix Corp. Derives de la phenyl-quinazolin-4(3h)-one et de la phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one et leurs compositions utiles comme agents anti-inflammatoires
LT2421533T (lt) 2009-04-22 2018-12-27 Resverlogix Corp. Nauji priešuždegiminiai agentai
JP5992049B2 (ja) 2011-11-01 2016-09-14 レスバーロジックス コーポレイション 置換されたキナゾリノンのための経口速放性製剤
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Dérivés biaryle servant d'inhibiteurs de bromodomaines
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
WO2016147053A1 (fr) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions et procédés thérapeutiques pour le traitement de maladies associées au complément

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5532267A (en) * 1992-02-10 1996-07-02 Torii & Co., Ltd. Amidinonaphthyl furancarboxylate derivatives and acid addition salts therof
US5470955A (en) 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
MX9700152A (es) 1994-07-08 1997-04-30 Astra Ab Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
TW430561B (en) 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
EP0803251B1 (fr) 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Formes solides d'administration de cisapride à libération immédiate et indépendente du PH
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
JP2001500875A (ja) * 1996-09-18 2001-01-23 メルク エンド カンパニー インコーポレーテッド 心臓血管系疾患関連の危険性を減らす併用治療法
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
GB9814215D0 (en) 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CA2239931A1 (fr) 1998-07-15 2000-01-15 Bernard Charles Sherman Comprime pharmaceutique comprenant de la norfloxacine
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
JP2002541092A (ja) 1999-04-06 2002-12-03 ファーマクエスト・リミテッド メチルフェニデートのパルス性送達のための薬学的投薬形態
AT4327U1 (de) 1999-04-13 2001-06-25 Beecham Pharm Pte Ltd Pharmazeutische formulierung

Also Published As

Publication number Publication date
DE69923074T2 (de) 2005-12-08
CN1158070C (zh) 2004-07-21
AU746129B2 (en) 2002-04-18
NZ539749A (en) 2006-11-30
KR100696350B1 (ko) 2007-03-20
IL141439A0 (en) 2002-03-10
RU2005100986A (ru) 2006-06-20
NZ509943A (en) 2004-01-30
ZA200101762B (en) 2002-06-03
PL195603B1 (pl) 2007-10-31
JP2002524412A (ja) 2002-08-06
TR200502188T2 (tr) 2006-12-21
AU5892499A (en) 2000-03-27
SA99200683B1 (ar) 2006-12-05
US6521253B1 (en) 2003-02-18
US20030118644A1 (en) 2003-06-26
TR200100666T2 (tr) 2001-08-21
EP1527787A1 (fr) 2005-05-04
KR20060097071A (ko) 2006-09-13
ES2234296T3 (es) 2005-06-16
DE69923074D1 (de) 2005-02-10
US20050208128A1 (en) 2005-09-22
IL141439A (en) 2006-07-05
RU2252751C2 (ru) 2005-05-27
WO2000013671A1 (fr) 2000-03-16
CN1315855A (zh) 2001-10-03
UA75567C2 (en) 2006-05-15
KR20010090436A (ko) 2001-10-18
BR9913400A (pt) 2001-05-22
SE9802973D0 (sv) 1998-09-03
ATE286385T1 (de) 2005-01-15
JP2007039472A (ja) 2007-02-15
CZ2001774A3 (cs) 2001-10-17
CA2341397A1 (fr) 2000-03-16
AR029313A1 (es) 2003-06-25
PT1109537E (pt) 2005-04-29
CN1544088A (zh) 2004-11-10
NO20011085D0 (no) 2001-03-02
HUP0103886A2 (hu) 2002-04-29
CZ300830B6 (cs) 2009-08-19
CN1951371A (zh) 2007-04-25
EP1109537B1 (fr) 2005-01-05
IS5869A (is) 2001-02-28
PL346545A1 (en) 2002-02-11
JP4026678B2 (ja) 2007-12-26
TW561056B (en) 2003-11-11
MY124359A (en) 2006-06-30
US6875446B2 (en) 2005-04-05
SK2812001A3 (en) 2001-09-11
NO20011085L (no) 2001-05-03
EE200100134A (et) 2002-06-17
HU227278B1 (en) 2011-01-28
SK285507B6 (sk) 2007-03-01
HUP0103886A3 (en) 2002-08-28
EP1109537A1 (fr) 2001-06-27
CA2341397C (fr) 2009-02-03

Similar Documents

Publication Publication Date Title
ID29629A (id) Tablet yang lapas-segera
ID26334A (id) Morfolinol yang aktif secara farmasi
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
DK0943331T3 (da) Formuleringer indeholdende oxaliplatin
DK0994865T3 (da) Triazolforbindelser og anvendelsen deraf som dopamin-D3-ligander
DE19983151T1 (de) Bandabroller
DE69914886D1 (de) Abbildungsgerät
DE69814927D1 (de) Klebebandspender
ID23735A (id) Tablet trovafloksasin mesilat
ID22233A (id) Tablet telan yang terdiri dari parasetamol
ID22589A (id) Piranti tampilan yang dapat diprogram
NO994698L (no) Fremviserenheter
DE59909297D1 (de) Carbonyleisensilizid-Pulver
DE59908239D1 (de) Klebestreifen
DK1137581T3 (da) Tabletæske
NO20010154D0 (no) Brönnhulls-strekksvivelovergang
DE69915818D1 (de) Zuckerbeschichtete tabletten
DE29801440U1 (de) Tabletten-Einnahmehilfe
DE29815170U1 (de) Monitorgehäuse
DE59900733D1 (de) Steckverbinder
DE59903821D1 (de) Steckverbinder
DE50005969D1 (de) Verpackungs-Klebeband
DE29817549U1 (de) Reißverschluß
DE29813390U1 (de) Doppelseitiges Klebeband
DE29813269U1 (de) Tablette